Terns Pharmaceuticals Inc (TERN) stock saw a decline, ending the day at $10.02 which represents a decrease of $-0.02 or -0.20% from the prior close of $10.04. The stock opened at $10.25 and touched a ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

OrbiMed Advisors LLC, a prominent investment firm, executed a significant transaction by acquiring an additional 6,807,336 shares of Terns Pharmaceuticals Inc (NASDAQ:TERN). This purchase was made at ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see a ...

Structure Therapeutics (NASDAQ:GPCR), and Terns Pharmaceuticals (NASDAQ:TERN), which are all developing oral pills as weight loss treatments, are trading higher Friday following disappointing results ...

An $11.8 million project to help some of the Niagara River’s smallest fish swim upstream against the strong current could help restore some balance to the Lake Erie and Niagara River ecosystems.

New public and private entrants are emerging to challenge the leading positions of Novo Nordisk NVO and Eli Lilly LLY in a ...

Mizuho has recently initiated Terns Pharmaceuticals Inc (TERN) stock to Buy rating, as announced on June 22, 2023, according to Finviz. Earlier, on June 7, 2023, Jefferies had initiated the stock to ...

IPOs at three biotechs last week tempted insiders to make huge share purchases. This spilled over into buying at a couple of ...